financetom
Business
financetom
/
Business
/
Top Premarket Decliners
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Decliners
Apr 30, 2024 5:28 AM

08:01 AM EDT, 04/30/2024 (MT Newswires) -- Medifast ( MED ) shares slipped over 25% in recent Tuesday premarket activity a day after it posted lower Q1 earnings per share and revenue from a year earlier.

Lichen China ( LICN ) shares tumbled 20%, reversing from Monday's 48% gain.

Chegg ( CHGG ) stock fell 17% a day after it reported lower Q1 non-GAAP net income per share and net revenue from a year earlier.

Coursera ( COUR ) stock was down more than 14% a day after issuing a lower-than-expected Q2 and full-year 2024 revenue outlook.

Price: 26.80, Change: -8.71, Percent Change: -24.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TotalEnergies Sells 50% Stake in Greek Renewables Portfolio for $595.4 Million
TotalEnergies Sells 50% Stake in Greek Renewables Portfolio for $595.4 Million
Mar 10, 2026
04:46 AM EST, 12/17/2025 (MT Newswires) -- TotalEnergies SE ( TTE ) said Wednesday that it has completed the sale of a 50% stake in its 424 MW wind and solar portfolio in Greece to Asterion Industrial Partners for 508 million euros ($595.4 million), or about 1.2 million euros per MW. The company said the sale fits its renewable strategy...
Update: Rezolve Ai Reaffirms Recurring Sales Outlook Over $200 Million; Shares Extend Gains Premarket
Update: Rezolve Ai Reaffirms Recurring Sales Outlook Over $200 Million; Shares Extend Gains Premarket
Mar 10, 2026
04:51 AM EST, 12/17/2025 (MT Newswires) -- (Updates with the stock move in the headline and the third paragraph.) Rezolve Ai ( RZLV ) said Tuesday it expects December revenue to exceed $17 million and reaffirmed its full-year 2026 recurring revenue outlook of $500 million or more. One analyst surveyed by FactSet expects $264 million. The company's estimates are based...
Sinclair Issues Statement on Merger Proposal with The E.W. Scripps Company
Sinclair Issues Statement on Merger Proposal with The E.W. Scripps Company
Mar 10, 2026
BALTIMORE--(BUSINESS WIRE)-- Sinclair, Inc. ( SBGI ) (the “Company” or “Sinclair”) today made the following statement in response to The E.W. Scripps Company’s (“Scripps”) rejection of the Company’s proposal for a potential combination with Scripps: “We are disappointed that despite Scripps encouraging Sinclair to make a proposal, Scripps’ board rejected the proposal without engaging. Our proposal was based on previous...
Sanofi Says Efdoralprin Alfa Gets Orphan Drug Designation in EU
Sanofi Says Efdoralprin Alfa Gets Orphan Drug Designation in EU
Mar 10, 2026
04:54 AM EST, 12/17/2025 (MT Newswires) -- Sanofi ( SNY ) said Wednesday its investigational efdoralprin alfa fusion protein has received the European Medicines Agency's orphan drug designation to potentially treat alpha-1 antitrypsin deficiency-related emphysema, a rare respiratory condition. The decision was based on efdoralprin alfa meeting all primary and secondary endpoints in a global phase 2 trial. Efdoralprin alfa...
Copyright 2023-2026 - www.financetom.com All Rights Reserved